Purpose of Review

Chronic foot pain constitutes a large portion of the chronic pain burden in the overall population. Plantar fasciitis is one of the most common and most easily identifiable causes of chronic foot pain. The syndrome has been estimated to cause 11 to 15% of foot pain visits, requiring professional care. Moreover, studies have suggested that 1 in 10 people will develop plantar fasciitis at some point in their life. Conservative management has been shown to be effective and considered first-line treatment. Minimally invasive treatment options are typically reserved for those who fail conservative management. With the advent of new techniques and improvements in current therapeutic options, there has been an expansion of available minimally invasive treatment options. The purpose of this review is to provide a comprehensive update on the current understanding of minimally invasive treatments of plantar fasciitis.

Recent Findings

This review shows that conservative management continues to be the first-line therapy, whereas other treatment options were those who failed conservative management using modern techniques that have shown improving effectiveness, with successful restoration of patient functionality, recovery, and satisfaction. However, a multitude of these minimally invasive treatment options are evolving.

Conclusion

While conservative management continues to be the mainstay of treatment for plantar fasciitis, multiple minimally invasive treatment options are emerging with potential effectiveness in reducing pain and improving the function.

中文翻译：

---

足底筋膜炎微创治疗方案的最新概念：综述。

审查目的

慢性足痛在整个人群中占了慢性痛负担的很大一部分。足底筋膜炎是慢性足痛的最常见且最容易确定的原因之一。据估计，该综合征可导致11至15％的足部疼痛就诊，需要专业护理。此外，研究表明每10个人中就有1个人会在其生活中的某个时候发生足底筋膜炎。保守治疗已被证明是有效的，被认为是一线治疗。微创治疗方案通常保留给那些保守治疗失败的人。随着新技术的出现和当前治疗方法的改进，可用微创治疗方法的扩展。

最近的发现

该评价表明，保守治疗仍然是一线治疗，而其他治疗选择是那些使用现代技术未能实现保守治疗的治疗方法，这些技术已显示出改善的功效，并成功恢复了患者的功能，康复和满意度。然而，许多这些微创治疗选择正在发展。

结论

虽然保守治疗仍然是足底筋膜炎的主要治疗手段，但多种微创治疗方案正在涌现，具有减轻疼痛和改善功能的潜在功效。